N J Roberts1, L Kidd2, N Dougall3, I S Patel4, S McNarry5, C Nixon6. 1. Institute for Applied Health Research, School of Health and Life Sciences Glasgow Caledonian University, Cowcaddens Road, Glasgow G4 0BA, UK. Electronic address: nicola.roberts@gcu.ac.uk. 2. School of Nursing & Midwifery, Robert Gordon University, Garthdee Road, Aberdeen AB10 7QG, UK. 3. Nursing Midwifery and Allied Health Professions Research Unit School of Health Sciences, University of Stirling, Unit 13 Scion House, Stirling FK9 4NF, UK. 4. King's Health Partners Academic Health Sciences Centre, London, UK. 5. Pulmonary Rehabilitation, Edinburgh Community Health Partnership, NHS Lothian, UK. 6. Co-creating Health Project Team, Ayrshire Central General Hospital, Irvine KA12 8SS, UK.
Abstract
OBJECTIVE: Patient activation can be measured using the Patient Activation Measure (PAM) developed by Hibbard et al., however, little is known about the uses of the PAM in research and in practice. This study aims to explore its differing utility in four UK exemplar sites. METHODS: Data from four exemplars in a range of health settings with people living with long-term conditions (i.e. stroke or COPD) were evaluated. PAM scores were described and explored in relation to clinical and sociodemographic variables and outcome measures. RESULTS: PAM scores illustrated that most with COPD or stroke reported PAM levels of 3 or 4, indicating that they are engaging, but may need help to sustain their scores. The exemplars illustrate the utility of, and potential issues involved in, using PAM as a process/outcome measure to predict activation and the effectiveness of interventions, and as a tool to inform tailoring of targeted interventions. CONCLUSIONS: The PAM tool has been shown to be useful as an outcome measure, a screening tool to tailor education, or a quality indicator for delivery of care. PRACTICE IMPLICATIONS: However good demographic and patient history are needed to substantiate PAM scores. Further work is needed to monitor PAM prospectively.
OBJECTIVE:Patient activation can be measured using the Patient Activation Measure (PAM) developed by Hibbard et al., however, little is known about the uses of the PAM in research and in practice. This study aims to explore its differing utility in four UK exemplar sites. METHODS: Data from four exemplars in a range of health settings with people living with long-term conditions (i.e. stroke or COPD) were evaluated. PAM scores were described and explored in relation to clinical and sociodemographic variables and outcome measures. RESULTS: PAM scores illustrated that most with COPD or stroke reported PAM levels of 3 or 4, indicating that they are engaging, but may need help to sustain their scores. The exemplars illustrate the utility of, and potential issues involved in, using PAM as a process/outcome measure to predict activation and the effectiveness of interventions, and as a tool to inform tailoring of targeted interventions. CONCLUSIONS: The PAM tool has been shown to be useful as an outcome measure, a screening tool to tailor education, or a quality indicator for delivery of care. PRACTICE IMPLICATIONS: However good demographic and patient history are needed to substantiate PAM scores. Further work is needed to monitor PAM prospectively.
Authors: Courtney J Lightfoot; Thomas J Wilkinson; Katherine E Memory; Jared Palmer; Alice C Smith Journal: Clin J Am Soc Nephrol Date: 2021-06-11 Impact factor: 10.614
Authors: Amy Blakemore; Mark Hann; Kelly Howells; Maria Panagioti; Mark Sidaway; David Reeves; Peter Bower Journal: BMC Health Serv Res Date: 2016-10-18 Impact factor: 2.655
Authors: Edward Zimbudzi; Clement Lo; Sanjeeva Ranasinha; Peter G Kerr; Kevan R Polkinghorne; Helena Teede; Timothy Usherwood; Rowan G Walker; Greg Johnson; Greg Fulcher; Sophia Zoungas Journal: Health Expect Date: 2017-07-04 Impact factor: 3.377